v3.26.1
Medtronic Agreement (Details) - USD ($)
3 Months Ended
Aug. 28, 2025
Aug. 04, 2025
Mar. 31, 2026
Mar. 31, 2025
Jul. 31, 2025
Medtronic Agreement          
Aggregate purchase price     $ 5,855,000    
Public Offering          
Medtronic Agreement          
Additional shares to be purchased 2,182,500        
Medtronic, Inc.          
Medtronic Agreement          
Reimbursable research and development expense     2,600,000 $ 3,400,000  
Revenue recognized to date     0    
Medtronic, Inc. | Series D-2 Preferred Stock          
Medtronic Agreement          
Proceeds from issuance of Series D-2 Preferred Stock     40,000,000    
Medtronic, Inc. | Private Placement | Related Party          
Medtronic Agreement          
Shares issued (in shares) 132,282 4,077,427      
Share issue price (in dollars per share) $ 2.75 $ 2.75      
Aggregate purchase price $ 363,775 $ 11,200,000      
Medtronic, Inc. | Loan Agreement | Secured Subordinated Convertible Promissory Note (the "Notes")          
Medtronic Agreement          
Term loan         $ 20,000,000
Minimum | Medtronic, Inc.          
Medtronic Agreement          
Expected to receive product price     500    
Maximum | Medtronic, Inc.          
Medtronic Agreement          
Expected to receive product price     1,600    
Accounts Payable and Accrued Expenses | Medtronic, Inc.          
Medtronic Agreement          
Reimbursable research and development expense     $ 2,600,000